The present study was prompted by the observation that, in patients with chronic renal failure being followed at this center, renal osteodystrophy developed almost exclusively in those who were treated by chronic hemodialysis at home rather than in our center. A systematic comparison was made between the 10 patients with roentgenographic evidence of the bone disease and 18 patients without demonstrable bone disease. The two groups were similar in age, sex, nature of renal disease, and duration of dialysis. The mean duration of kidney disease was almost 2 yr longer in the patients without bone disease than in those with bone disease. Other significant differences related to where the hemodialysis was performed and to the calcium concentration in the dialysate (6.0-7.4 mg/100 ml in the hospital and 4.9-5.6 mg/100 ml at home). If the unknown factors related to where the dialysis was performed were of no consequence, the major factor contributing to the production of bone disease observed in these patients was the use of a dialysate with a calcium concentration less than 5.7 mg/100 ml.
Albert E. Fournier, William J. Johnson, Donald R. Taves, John W. Beabout, Claude D. Arnaud, Ralph S. Goldsmith
Title and authors | Publication | Year |
---|---|---|
Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part)
TB Drueke, M Touam |
Nephrology Dialysis Transplantation | 2009 |
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients
M Monge, I Shahapuni, R Oprisiu, NE Esper, P Morinière, Z Massy, G Choukroun, A Fournier |
Nature Clinical Practice Nephrology | 2006 |
Place des nouveaux traitements de l'ostéodystrophie rénale : dérivés 1α-hydroxylés de la vitamine D « non hypercalcémiants », complexants non calciques, non magnésiens et non aluminiques des phosphates, et calcimimétiques
L Harbouche, I Shahapuni, M Monge, B Araar, K Rahmouni, R Oprisiu, J Mansour, C Presne, IE Esper, F Boitte, NE Esper, P Morinière, M Brazier, Z Massy, G Choukroun, A Fournier |
Immuno-analyse & Biologie Spécialisée | 2006 |
Viewpoint: How Do Calcimimetics Fit Into the Management of Parathyroid Hormone, Calcium, and Phosphate Disturbances in Dialysis Patients?
I Shahapuni, J Mansour, L Harbouche, B Maouad, M Benyahia, K Rahmouni, R Oprisiu, JF Bonne, M Monge, NE Esper, C Presne, P Moriniere, G Choukroun, A Fournier |
Seminars in Dialysis | 2005 |
Pathologie osseuse et insuffisance rénale. Actualités sur les explorations biologiques
R Oprisiu, CP Crina, M Benhyahya, B Maouad, I Shaapuni, SM Naini, IE Esper, F Boitte, M Brazier, A Fournier |
Immuno-analyse & Biologie Spécialisée | 2003 |
The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium
S Frankenthal, F Nakhoul, EE Machtei, J Green, L Ardekian, D Laufer, M Peled |
Journal of Clinical Periodontology | 2002 |
Renal Osteodystrophy in Dialysis Patients: Diagnosis and Treatment
A Fournier, R Oprisiu, C Hottelart, PH Yverneau, A Ghazali, A Atik, H Hedri, S Said, A Sechet, M Rasolombololona, O Abighanem, A Sarraj, NE Esper, P Moriniere, B Boudailliez, PF Westeel, JM Achard, A Pruna |
Artificial Organs | 1998 |
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane |
Metabolic Bone Disease and Clinically Related Disorders | 1998 |
Control of Hyperphosphatemia in Renal Failure: Role of Aluminum
DM Kates, DL Andress |
Seminars in Dialysis | 1996 |
Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited
F Llach |
American Journal of Kidney Diseases | 1995 |
Parathyroid gland function in chronic renal failure
AJ Felsenfeld, F Llach |
Kidney International | 1993 |
Nutritional Treatment of Chronic Renal Failure
S Giovannetti |
1989 | |
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris |
Vitamin D | 1988 |
Osteopathien
S Bosnjakovic-Büscher, L Diethelm, HH Ellegast, H Fritz, I Greinacher, F Heuck, O Mehls, HC Oppermann, K Reinhardt, HW Schneider, J Spranger |
1983 | |
Radiographic changes of the jawbones in end stage renal disease
WH Kelly, MK Mirahmadi, JH Simon, JT Gorman |
Oral Surgery, Oral Medicine, Oral Pathology | 1980 |
Limit by hypherphosphatemia ofthe usefulness of vitamin D metabolites (1α-hydroxycholecalciferol and 25-hydroxycholecalciferol) in the treatment of renal osteodystrophy
JL Sebert, A Fournier, J Gueris, G Lambrey, JF Fremont, P Marie, R Makdassi, A Smadja, A Marie, D Kuntz, A Ryckewaert, J Quichaud, PJ Meunier |
Metabolic Bone Disease and Related Research | 1980 |
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher |
1979 | |
Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysis
JR Juttmann, JC Hagenouw-Taal, LD Lameyer, AM Ruis, JC Birkenhäger |
Calcified Tissue Research | 1978 |
Secondary Hyperparathyroidism in Chronic Renal Failure: Pathophysiology and Treatment
DA Hanley, LM Sherwood |
Medical Clinics of North America | 1978 |
Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy
T Drüeke, PJ Bordier, NK Man, P Jungers, P Marie |
Kidney International | 1977 |
THE ROLE OF PHOSPHATE IN RENAL BONE DISEASE
AM Pierides |
Clinical Endocrinology | 1977 |
Parathyroid Hormone, Calcium and Phosphate Balance in Hemofiltration
C Fuchs, B Doht, D Dorn, C McLntosh, D Ritter, F Scheler |
Renal Failure | 1977 |
Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis
PE Cordy |
Canadian Medical Association journal | 1977 |
Oral manifestations of secondary hyperparathyroidism related to long-term hemodialysis therapy
PD Fletcher, IW Scopp, RA Hersh |
Oral Surgery, Oral Medicine, Oral Pathology | 1977 |
Metabolic Bone Disease
OL Bijvoet |
Metabolic Bone Disease | 1977 |
Effects of Haemodialysis on Fractional Intestinal Absorption of Calcium in Uraemia
JM Chanard, T Drüeke, J Zingraff, NK Man, F Russo-Marie, JL Funck-Brentano |
European Journal of Clinical Investigation | 1976 |
The Use of High Calcium Dialysate in the Treatment of Renal Osteomalacia
RA Evans, PJ Somerville |
Australian and New Zealand Journal of Medicine | 1976 |
Dialysate calcium and plasma calcium fractions during and after haemodialysis
C Fuchs, M Brasche, U Donath-Wolfram, J Kubosch, E Quellhorst, F Scheler |
Klinische Wochenschrift | 1975 |
Abnormalities of the musculoskeletal system in hemodialysis patients
SG Massry, R Bluestone, JR Klinenberg, JW Coburn |
Seminars in Arthritis and Rheumatism | 1975 |
Renal excretion of fluoride in renal failure and after renal transplantation
V Parsons, AA Choudhury, JA Wass, A Vernon |
British medical journal | 1975 |
Calcium metabolism in renal failure
DS David |
The American Journal of Medicine | 1975 |
Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy
WM Sy, AK Mittal |
British Journal of Radiology | 1975 |
Calcium Metabolism, Bone and Metabolic Bone Diseases
F Kuhlencordt, HP Kruse |
1975 | |
Bone disease in hemodialysis patients with particular reference to the effect of fluoride
PE Cordy, R Gagnon, DR Taves, M Kaye |
Canadian Medical Association journal | 1974 |
Hyperparathyroid bone disease in children undergoing long-term hemodialysis; treatment with vitamin D
DE Potter, CJ Wilson, MB Ozonoff |
The Journal of Pediatrics | 1974 |
The hyperparathyroidism of renal failure: Pathophysiology and treatment
RS Goldsmith, WJ Johnson, CD Arnaud |
Clinics in Endocrinology and Metabolism | 1974 |
Calcium uptake and phosphate removal during hemodialysis with variing dialysate calcium
F Skrabal, P Dittrich, F Gabl |
Klinische Wochenschrift | 1974 |
Achtzigster Kongress: Gehalten zu Wiesbaden vom 21.–25. April 1974
JF Bergmann |
1974 | |
Etiology of Hyperparathyroidism and Bone Disease during Chronic Hemodialysis. III. EVALUATION OF PARATHYROID SUPPRESSIBILITY
RS Goldsmith, J Furszyfer, WJ Johnson, AE Fournier, GW Sizemore, CD Arnaud |
Journal of Clinical Investigation | 1973 |
Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy
RS Goldsmith, WJ Johnson |
Kidney International | 1973 |
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis
A Meyrier, J Marsac, G Richet |
Kidney International | 1973 |
Study on the influence of dialysis with varying bath calcium concentrations on the different plasma calcium fractions
R Verberckmoes |
Klinische Wochenschrift | 1972 |
Azotaemic renal osteodystrophy
SW Stanbury |
Clinics in Endocrinology and Metabolism | 1972 |
Alkaline Phosphatase
MM Kaplan |
New England Journal of Medicine | 1972 |
Prevention and Treatment of Progressive Secondary Hyperparathyroidism in Advanced Renal Failure
WJ Johnson, RS Goldsmith, CD Arnaud |
Medical Clinics of North America | 1972 |
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis II. Factors affecting serum immunoreactive parathyroid hormone
AE Fournier, CD Arnaud, WJ Johnson, WF Taylor, RS Goldsmith |
Journal of Clinical Investigation | 1971 |
Metabolic Abnormalities in Uremia
DM Wilson |
Medical Clinics of North America | 1971 |